-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core_Weighted.PDF
January 01, 2014 - PROCEDURES W CC 14,974 0.04%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 2,477 0.01%
682: RENAL … FAILURE W MCC 199,751 0.57%
683: RENAL FAILURE W CC 300,288 0.85%
684: RENAL FAILURE W/O CC/MCC 62,889 … Weighted Frequency Distribution for DRG_NOPOA
DRG_NoPOA Frequency
Percent
of Total
685: ADMIT FOR RENAL … of other male genital organs 900 0.00%
32: Cancer of bladder 28,210 0.08%
33: Cancer of kidney and renal … sclerosis 11,594 0.03%
157: Acute and unspecified renal failure 493,597 1.40%
158: Chronic kidney
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Dx_Pr_Grps.PDF
October 31, 2017 - PROCEDURES W CC 5,795 0.04%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 893 0.01%
682: RENAL … FAILURE W MCC 86,007 0.67%
683: RENAL FAILURE W CC 127,499 0.99%
684: RENAL FAILURE W/O CC/MCC 26,393 … 0.20%
685: ADMIT FOR RENAL DIALYSIS 1,931 0.01%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 1,263 … of other male genital organs 366 0.00%
32: Cancer of bladder 11,114 0.09%
33: Cancer of kidney and renal … sclerosis 4,055 0.03%
157: Acute and unspecified renal failure 211,947 1.64%
158: Chronic kidney disease
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core.PDF
January 01, 2013 - PROCEDURES W CC 6,883 0.05%
675: OTHER KIDNEY & URINARY TRACT PROCEDURES W/O CC/MCC 1,422 0.01%
682: RENAL … FAILURE W MCC 85,989 0.60%
683: RENAL FAILURE W CC 130,924 0.91%
684: RENAL FAILURE W/O CC/MCC 27,357 … 0.19%
685: ADMIT FOR RENAL DIALYSIS 2,385 0.02%
686: KIDNEY & URINARY TRACT NEOPLASMS W MCC 1,201 … of other male genital organs 411 0.00%
32: Cancer of bladder 13,026 0.09%
33: Cancer of kidney and renal … sclerosis 4,137 0.03%
157: Acute and unspecified renal failure 214,864 1.50%
158: Chronic kidney disease
-
hcup-us.ahrq.gov/toolssoftware/ccs/AppendixCMultiDX.txt
April 18, 2016 - 1884 1885 1886 1887 1888 1889
2337 V1051
2.9.2 Cancer of kidney and renal … -
24901 24910 24911 25002 25003 25010 25011 25012 25013
3.3.2 Diabetes with renal … complications and secondary hypertension [99.] 99
7.1.2.1 Hypertensive heart and/or renal … 156 157 158 159 160 161 162 163
10.1.1 Nephritis; nephrosis; renal … 5829 5830
5831 5832 5834 5836 5837 58381 58389 5839 587
10.1.2 Acute and unspecified renal
-
www.ahrq.gov/patient-safety/settings/esrd/resource/cultureofsafety.html
January 01, 2015 - Creating a Culture of Safety
ESRD Toolkit
The Creating a Culture of Safety module of the ESRD Toolkit discusses the importance of a comprehensive, unit-based approach to safety and its impact on improving patient care and reducing harm in dialysis centers.
Presentation Slides ( PPTX, 20 M B)
Facilitator …
-
www.ahrq.gov/patient-safety/settings/esrd/resource/checklist.html
January 01, 2015 - Using Checklists and Audit Tools
ESRD Toolkit
The Using Checklists and Audit Tools module of the ESRD Toolkit explains the importance of using data in the quality assurance and performance improvement process, and explains how implementing checklists and audit tools aligns with the principles of safe design. …
-
www.ahrq.gov/patient-safety/settings/esrd/resource/clinicalcare.html
January 01, 2015 - Clinical Care
ESRD Toolkit
The Clinical Care module of the ESRD Toolkit summarizes why proper clinical care is important in preventing vascular access infections, explains practices staff members can follow during site access to reduce infection risk, and describes ways to evaluate infection control practices…
-
www.ahrq.gov/patient-safety/settings/esrd/resource/tooluse.html
October 01, 2020 - How To Use the ESRD Toolkit
ESRD Toolkit
The toolkit consists of four instructional modules that a facilitator can use to teach dialysis center team members specific ways to create a culture of safety. The modules are modifiable to meet individual dialysis center training needs.
Modules of the ESRD Toolkit …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
February 01, 2013 - No
eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … unknown, but the disorder also occurs secondary to other
conditions such as iron deficiency, end-stage renal … No eligible studies enrolled individuals with end-stage renal disease, and almost all
specifically excluded … Investigate
the Safety and Efficacy of the Rotigotine
Skin Patch in Subjects With RLS and End-
Stage Renal … GEn 1200/6000mg; Placebo; Moxifloxacin
NCT00422994 A Study To Investigate The Effects Of End
Stage Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
November 19, 2009 - For example, intact
parathyroid hormone (PTH) measurements are used to manage patients with renal
osteodystrophy … of comparability of intact
parathyroid hormone measurements
among commercial assays for end-stage
renal
-
digital.ahrq.gov/sites/default/files/docs/page/09-0031-EF_cpoe.pdf
January 01, 2009 - drug interactions, patient allergies to prescribed
medications, medication contraindications, and renal … Guided medication dosing for
inpatients with renal insufficiency.
-
www.ahrq.gov/sites/default/files/2024-02/taber-report.pdf
January 01, 2024 - Kidney transplantation is considered the preferred treatment option for patients with end-stage
renal … Despite
this, long-term renal allograft survival remains largely unchanged during this time.
-
www.ahrq.gov/sites/default/files/2024-05/schoenfeld-report.pdf
January 01, 2024 - SDM in specific clinical scenarios
Renal Colic:
We are designing a study to help physicians use a shared … decision making decision aid for young healthy
patients with classical presentations of renal colic
-
digital.ahrq.gov/ahrq-funded-projects/emerging-lessons/computerized-provider-order-entry-inpatient/inpatient-computerized-provider-order-entry-cpoe
January 01, 2023 - include drug interactions, patient allergies to prescribed medications, medication contraindications, and renal … Guided medication dosing for inpatients with renal insufficiency.
-
psnet.ahrq.gov/perspective/patient-safety-home-dialysis
April 28, 2021 - ongoing communication between the patient and the care team. 7 Mitigating Safety Risks in End-Stage Renal … Could you start out by describing your current role and summarize how you engage with ESRD [end-stage renal
-
digital.ahrq.gov/sites/default/files/docs/lesson/09-0031-ef-inpatient-cpoe.pdf
January 01, 2009 - drug interactions, patient allergies to prescribed
medications, medication contraindications, and renal … Guided medication dosing for
inpatients with renal insufficiency.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
November 24, 2014 - More information regarding patients’ baseline characteristics,
particularly renal clearance, APACHE … results section, we have added more details when
available on baseline characteristics, particularly renal … In the Results section we added data on baseline
characteristics, particularly renal clearance, APACHE … ,
or antibiotic-related adverse events differ for subgroups
defined by age, sex, race, ethnicity, renal
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/asymptomatic-bacteriuria-in-adults-screening
September 24, 2019 - 25 , 26 , 33
Exclusion criteria were generally not specified or limited (eg,hypertensive, chronic renal … research on the microbiome has led to discoveries of protective bacterial colonization, including in the renal … Subclinical renal infection and prematurity. Med J Aust . 1969;2(12):596-600.
25.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
December 01, 2015 - -
vascular mortality and morbidity and may also result in
other complications, such as vision loss, renal … Diabetes is the leading cause of kid-
ney failure, accounting for more than 44% of new cases
of end-stage renal … Effects of ramipril and
rosiglitazone on cardiovascular and renal outcomes in people with
impaired glucose
-
hcup-us.ahrq.gov/reports/methods/2004_07.pdf
January 01, 2004 - admissions and transfers from
other institutions) per 100,000 population, age 18 years and older
* Renal … population, age 18 years and older
* Without short-term (ketoacidosis, hyperosmolarity, coma) or long-term (renal … disease* and obstetric admissions)
* That is, excluding patients with diabetic coma and patients with renal